Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Series A-5 Preferred Stock [Member]
Preferred Stock [Member]
Series AA Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series AA-2 Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series AA-3 Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series AA-4 Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series AA-5 Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Melon Acquisition [Member]
Common Stock [Member]
Superbiz Acquisition [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Series A-5 Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series AA Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series AA-2 Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series AA-3 Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series AA-4 Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series AA-5 Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Melon Acquisition [Member]
Additional Paid-in Capital [Member]
Superbiz Acquisition [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Total stockholders’ equity               $ 0     $ 46,000                 $ 215,943,000 $ (125,292,000)  
Balance (in shares) at Dec. 31, 2021               0                            
Issuance of Series A preferred stock at $1,000 per share (in shares) 0 0 0 0 0 0                                
Conversion of Series A preferred stock (in shares)             0       0                      
Balance (in shares) at Jun. 30, 2022               0     37,043,778                      
Balance at Dec. 31, 2021               $ 0     $ 46,000                 215,943,000 (125,292,000)  
Issuance of Series A preferred stock at $1,000 per share $ 0 $ 0 $ 0 $ 0 $ 0 $ 0           $ 0 $ 0 $ 0 $ 0 $ 0 $ 0          
Conversion of Series A preferred stock             $ 0       0                      
Balance at Jun. 30, 2022               0     $ 46,000                 218,050,000 (141,928,000) $ 76,168,000
Balance (in shares) at Dec. 31, 2021                     36,809,187                      
Common stock issued for Acquisition (in shares)                 0 0                        
Stock-based compensation (in shares)                     177,166                      
Other (in shares)                     57,425                      
Stock-based compensation                     $ 0                 2,099,000    
Common stock issued for Acquisition                 $ 0 $ 0               $ 0 $ 0      
Common stock purchase warrants issued to placement agent                                       0    
Other                                       8,000    
Net Loss                                         (16,636,000) (16,636,000)
Total stockholders’ equity               $ 0     $ 46,000                 217,042,000 (133,208,000)  
Balance (in shares) at Apr. 03, 2022               0                            
Issuance of Series A preferred stock at $1,000 per share (in shares) 0 0 0 0 0 0                                
Conversion of Series A preferred stock (in shares)             0       0                      
Balance (in shares) at Jun. 30, 2022               0     37,043,778                      
Balance at Apr. 03, 2022               $ 0     $ 46,000                 217,042,000 (133,208,000)  
Issuance of Series A preferred stock at $1,000 per share $ 0 $ 0 $ 0 $ 0 $ 0 $ 0           0 0 0 0 0 0          
Conversion of Series A preferred stock             $ 0       0                      
Balance at Jun. 30, 2022               0     $ 46,000                 218,050,000 (141,928,000) 76,168,000
Balance (in shares) at Apr. 03, 2022                     36,864,957                      
Common stock issued for Acquisition (in shares)                 0 0                        
Stock-based compensation (in shares)                     121,396                      
Other (in shares)                     57,425                      
Stock-based compensation                     $ 0                 1,000,000    
Common stock issued for Acquisition                 $ 0 $ 0               0 0      
Common stock purchase warrants issued to placement agent                                       0    
Other                                       8,000    
Net Loss                                         (8,720,000)  
Total stockholders’ equity               0     46,000                 218,050,000 (141,928,000) 76,168,000
Total stockholders’ equity               $ 0     $ 47,000                 229,900,000 (210,743,000) $ 19,204,000
Balance (in shares) at Dec. 31, 2022               10,323                            
Issuance of Series A preferred stock at $1,000 per share (in shares) 2,299 7,680 1,500 1,025 1,026 550                                
Conversion of Series A preferred stock (in shares)             (4,511)       7,995,105                      
Balance (in shares) at Jun. 30, 2023               19,892     48,334,818                     48,334,818
Balance at Dec. 31, 2022               $ 0     $ 47,000                 229,900,000 (210,743,000) $ 19,204,000
Issuance of Series A preferred stock at $1,000 per share $ 0 $ 0 $ 0 $ 0 $ 0 $ 0           1,919,000 6,518,000 1,370,000 892,000 893,000 479,000          
Conversion of Series A preferred stock             $ 0       8,000                      
Balance at Jun. 30, 2023               0     $ 57,000                 241,833,000 (224,815,000) $ 17,075,000
Balance (in shares) at Dec. 31, 2022                     37,605,973                     37,605,973
Common stock issued for Acquisition (in shares)                 1,556,663 987,973                        
Stock-based compensation (in shares)                     189,104                      
Other (in shares)                     0                      
Stock-based compensation                     $ 0                 1,406,000    
Common stock issued for Acquisition                 $ 1,000 $ 1,000               721,000 547,000      
Common stock purchase warrants issued to placement agent                                       (2,804,000)    
Other                                       (8,000)    
Net Loss                                         (14,072,000) $ (14,072,000)
Total stockholders’ equity               $ 0     $ 47,000                 232,539,000 (217,979,000)  
Balance (in shares) at Mar. 31, 2023               12,622                            
Issuance of Series A preferred stock at $1,000 per share (in shares) 0 7,680 1,500 1,025 1,026 550                                
Conversion of Series A preferred stock (in shares)             (4,511)       7,995,105                      
Balance (in shares) at Jun. 30, 2023               19,892     48,334,818                     48,334,818
Balance at Mar. 31, 2023               $ 0     $ 47,000                 232,539,000 (217,979,000)  
Issuance of Series A preferred stock at $1,000 per share $ 0 $ 0 $ 0 $ 0 $ 0 $ 0           $ 0 $ 6,518,000 $ 1,370,000 $ 892,000 $ 893,000 $ 479,000          
Conversion of Series A preferred stock             $ 0       8,000                      
Balance at Jun. 30, 2023               0     $ 57,000                 241,833,000 (224,815,000) $ 17,075,000
Balance (in shares) at Mar. 31, 2023                     37,795,077                      
Common stock issued for Acquisition (in shares)                 1,556,663 987,973                        
Stock-based compensation (in shares)                     0                      
Other (in shares)                     0                      
Stock-based compensation                     $ 0                 686,000    
Common stock issued for Acquisition                 $ 1,000 $ 1,000               $ 721,000 $ 547,000      
Common stock purchase warrants issued to placement agent                                       (2,804,000)    
Other                                       (8,000)    
Net Loss                                         (6,836,000) (6,836,000)
Total stockholders’ equity               $ 0     $ 57,000                 $ 241,833,000 $ (224,815,000) $ 17,075,000